Literature DB >> 1374844

Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides.

S C Ying1, E Shephard, F C de Beer, J N Siegel, D Harris, B E Gewurz, M Fridkin, H Gewurz.   

Abstract

We recently described 17 anti-CRP mAb, seven to native- (or conformational) and 10 to neo- (or sequence-determined) epitopes, including several anti-neo-CRP mAb specific for CRP peptide 199-206. In the present study, four new anti-native- and four new anti-neo-CRP mAb were generated and characterized by ELISA reactivity with native and modified human and rabbit CRP, as well as binding to pronase fragments of human CRP in Western blots. Assays with 17 synthetic CRP peptides identified anti-neo-CRP mAb specific for peptides 1-16, 14-24 and 137-152, respectively. The anti-neo-CRP mAb were reacted with fragments obtained by digesting CRP with multiple additional enzymes, including Staphylococcal V8 protease, trypsin, elastase, plasmin, thrombin and alpha-chymotrypsin. Native CRP was remarkably resistant to enzymic digestion, particularly in the presence of calcium, but was readily cleavable upon denaturation. Twenty-three informative fragments served to further distinguish mAb reactivity with at least four additional neo-CRP epitopes, which presumptively included residues in the regions of amino acids 22-45, 41-61, 114-121 and 130-138, respectively. The eight epitopes identified corresponded well with predicted regions of CRP antigenicity. In addition, at least six distinct native or conformation-determined epitopes were delineated. Reactivity of the anti-neo-CRP mAb with fragments of CRP generated by PMN enzymes indicated that regions sensitive to cleavage by neutrophil enzymes are located at approximately 3, 10 and 16 kD from the amino terminus of the CRP subunit. We expect that the anti-CRP mAb described and mapped herein will be useful tools for the elucidation of CRP structure and function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374844     DOI: 10.1016/0161-5890(92)90205-c

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

1.  Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP).

Authors:  C Suankratay; C Mold; Y Zhang; L A Potempa; T F Lint; H Gewurz
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

2.  Identification of acidic pH-dependent ligands of pentameric C-reactive protein.

Authors:  David J Hammond; Sanjay K Singh; James A Thompson; Bradley W Beeler; Antonio E Rusiñol; Michael K Pangburn; Lawrence A Potempa; Alok Agrawal
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

Review 3.  Regulation of C-reactive protein conformation in inflammation.

Authors:  ZhenYu Yao; Yanmin Zhang; HaiBin Wu
Journal:  Inflamm Res       Date:  2019-07-16       Impact factor: 4.575

4.  Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein.

Authors:  Karolina E Taylor; Carmen W van den Berg
Journal:  Immunology       Date:  2006-12-08       Impact factor: 7.397

Review 5.  Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.

Authors:  Naeem Ullah; Yi Wu
Journal:  Cell Biochem Biophys       Date:  2022-08-23       Impact factor: 2.989

6.  Autoantibodies against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis.

Authors:  Qiu-Yu Li; Hai-Yun Li; Ge Fu; Feng Yu; Yi Wu; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121

7.  An ELISA Assay for Quantifying Monomeric C-Reactive Protein in Plasma.

Authors:  Lin Zhang; Hai-Yun Li; Wei Li; Zhi-Yuan Shen; Yin-Di Wang; Shang-Rong Ji; Yi Wu
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

Review 8.  The Multiple Faces of C-Reactive Protein-Physiological and Pathophysiological Implications in Cardiovascular Disease.

Authors:  Magdalena Boncler; Yi Wu; Cezary Watala
Journal:  Molecules       Date:  2019-05-30       Impact factor: 4.927

9.  Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification.

Authors:  Lawrence A Potempa; Zhen-Yu Yao; Shang-Rong Ji; János G Filep; Yi Wu
Journal:  Biophys Rep       Date:  2015-07-18

Review 10.  How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression.

Authors:  Ibraheem M Rajab; Peter C Hart; Lawrence A Potempa
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.